Clinical Trial Update: Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

View source ↗

Summary

A clinical trial update describing biomarkers and clinical features of metastatic breast cancer in patients treated with CDK4/6 inhibitors; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Palbociclib (palbociclib)
• Ribociclib (ribociclib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Status: RECRUITING